Navigation Links
TELINTRA® Named One of the 10 Most Interesting Oncology Projects to Watch
Date:10/26/2010

gnosed each year in the United States, with survival rates ranging from six months to six years.  MDS patients often require blood transfusions to manage their disease.

There remains a critical need for effective, well tolerated therapies for MDS.  Telintra has a novel mechanism of action that inhibits an enzyme called glutathione S-transferase P11 which may activate JNK kinase, a key regulator of cellular growth and differentiation of blood precursor cells.  Telintra has been shown to stimulate normal multilineage differentiation of blood stem cell precursors and induce cancer cell death, or apoptosis, in human leukemia cell lines.  Telintra is currently being evaluated in Phase 2 studies alone and in combination in patients with Low to Intermediate-1 Risk Myelodysplastic Syndrome and in Severe Chronic Neutropenia.

About Telik

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer.  The company's most advanced drug candidates in clinical development are Telintra, a modified glutathione analog for the treatment of MDS and Severe Chronic Neutropenia (SCN), and Telcyta®, a cancer activated prodrug for the treatment of advanced non-small cell lung cancer and ovarian cancer.  Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small molecule drug candidates.

This press release contains "forward looking" statements regarding the future development of Telintra, the effectiveness of Telintra in treating MDS alone and in combination with other drugs, the effectiveness of Telintra in treating Severe Chronic Neutropenia and other hematologic diseases, the effect of Telintra on leukemia cells and blood cell growth and differentiation, and the use of Telcyta for the treatment of advanced non-small cell lung cancer
'/>"/>

SOURCE Telik, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
2. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
3. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
4. Integrated Project Management Named to "Inc. 5000" for Second Year : One of the Top 100 Fastest-Growing Companies in Chicago Area
5. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
6. Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
7. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
8. Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN(R)
9. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
10. Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year
11. NovaVision CEO Named Presenter at the AdvaMed 2008 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... (PRWEB) March 31, 2015 This June ... from the top U.S and International Medical Schools will ... latest research on the application of stem cell therapy ... symposium is organized and funded by the Ocular ... that has been convening intimate meetings of top experts ...
(Date:3/30/2015)... Francisco, CA (PRWEB) March 30, 2015 ... tax incentives provided you the government, major companies are ... and local governments setting future mandates for renewable energy ... as an option. , Solara Power is a new ... several incentive programs available that allow qualifying homeowners to ...
(Date:3/30/2015)... , March 30, 2015  NuGene International, Inc. ... corporation, NuGene BioPharma, Inc. has added another internationally ... Dr. Guan is an internationally recognized researcher in ... college education at Peking University, China ... from the University of North Carolina, Chapel Hill. ...
(Date:3/30/2015)... , March 30, 2015 /CNW/ - A new national ... the salaries and demographic profiles of new graduates entering ... Door – Building Careers for New Grads in Biotech," ... Research-Based Pharmaceutical Companies (Rx&D) and features data collected ... Focus wage subsidy program from 2013 to 2015. ...
Breaking Biology Technology:Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2Solara Power Announces Residential Solar Power with No Up-Front Fees 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 2New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 3New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 4
... PAREXEL International,Corporation (Nasdaq: PRXL ) announced today ... Conference in Boston, MA. Josef von,Rickenbach, Chairman and Chief ... at 3:50 p.m. EDT on Thursday, September 4, 2008., ... available under the,"Upcoming Events" section on PAREXEL,s "Investors" homepage ...
... LLC, a New Jersey-based,leading provider of prescription co-pay ... has significantly expanded the scope of,the lawsuit that ... of the State,of New York, County of New ... subsidiary of McKesson Corporation. PSKW is,now seeking, in ...
... NATICK, Mass. and MUNICH, Germany, Sept. 1 ... today announced one-year data,from its landmark SYNTAX ... TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent,System to contemporary ... results demonstrated no statistically significant differences,between PCI ...
Cached Biology Technology:PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference 2PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKesson's Patent Application 2Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 2Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 3Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 4Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 5
(Date:3/23/2015)... , March 23, 2015 SoundView Technology Group issues ... (NASDAQ: NXTD ) Wocket smart wallet. SoundView was one of ... on their experience with the Wocket in multiple scenarios and ... Whole Foods and other retailers, making both debit and credit ... also says, "If the company meets their plans in ...
(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period ...
(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... , April 17, 2013 Vermillion, Inc. (NASDAQ: ... on gynecologic cancers and women,s health, announced the signing of ... U.S. Army Medical Research and Materiel Command (USAMRMC). ... Reduction Using OVA1 in a Treatment Algorithm for Adnexal ...
... 100% biodiesel (B100) "blend stock" samples by the U.S. ... that 95% of the samples from 2011-12 met ASTM ... guidelines for industry and are designed to ensure quality ... operation of the nation,s vehicles powered by biodiesel blends. ...
... 16, 2013 - BGI Health and ACIBADEM Healthcare ... Company Molecular Biology, signed a Memorandum of Understanding ... technologies to Turkey and improving Turkish reproductive healthcare. ... testing technologies in the areas of Monogenic disorders, ...
Cached Biology News:U.S. Army and Vermillion to Assess Health and Economic Benefits of OVA1 as a Standard of Care 2U.S. Army and Vermillion to Assess Health and Economic Benefits of OVA1 as a Standard of Care 3U.S. Army and Vermillion to Assess Health and Economic Benefits of OVA1 as a Standard of Care 4NREL survey shows dramatic improvement in B100 biodiesel quality 2BGI Health forms partnership with ACIBADEM hospital on genetic disease testing 2
Size & Applications: 100 ul (2 mM). Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.) Storage Temp.: -20C Shelf Life: 6-12 month...
NM522 contains an F episome, which is required for production of ssDNA and for blue/white color selection. To maintain the F, NM522 should be grown on minimal (M-9) medium....
Request Info...
...
Biology Products: